Corneal cross-linking at the Bay Area Eye Institute
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, received FDA approval in 2016 for corneal cross-linking, a medical procedure that combines the use of ultra-violet (UV) light and riboflavin (vitamin B2) eye drops.
Corneal Collagen Cross-Linking:
- Creates new corneal collagen cross-links
- Results in a shortening and thickening of the collagen fibrils
- Leads to the stiffening of the cornea and stabilization of the disease
Corneal cross-linking provides patients a much-needed option to treat this debilitating disease. Patients suffering from progressive keratoconus can now receive a therapeutic treatment that has been rigorously tested and approved.
Since FDA approval in 2016, Dr. Craig Berger and his experienced team has helped hundreds of keratoconus patients with this minimally invasive in office treatment.
Proven to halt progression, corneal collagen cross-linking for keratoconus is AVAILABLE at the Bay Area Eye Institute in Tampa, Florida.
Experience matters when choosing where to have your cross-linking. Dr. Berger is a cornea fellowship trained surgeon with over 20 years experience caring for keratoconus patients. He has successfully treated hundreds of keratoconus patients saving them from further loss of vision and the possibility of needing a cornea transplant. In addition to cross linking he and his staff offer the latest in contact lens technology. For those who cannot be helped with cross linking or contacts he excels at cornea transplants. No matter what stage of keratoconus you have, Dr. Berger can help!
Call (813) 265-6940 today to schedule your appointment today for your keratoconus evaluation and find out which treatment is right for you!